A prostate measured at 180 and PSA 11.5. I am 76 and have no health problems and feel great. To be sure this week I...

Let me address your questions systematically based on current medical evidence.

Understanding Your Situation

First, some context: You have metastatic prostate cancer (cancer that has spread to lymph nodes), which is also called stage 4 or advanced-stage disease. The good news is that prostate cancer, even at this stage, often responds well to treatment, and many patients live for years with effective management.

---

1) Options to Prevent Cancer Growth / Keep It Stable

Primary Treatment Approach: Hormone Therapy (Androgen Deprivation Therapy)

According to NCCN Guidelines for Advanced-Stage Prostate Cancer, the standard first-line treatment for metastatic prostate cancer that hasn't yet become hormone-resistant is Androgen Deprivation Therapy (ADT), sometimes called hormone therapy.

How it works: Prostate cancer cells depend on testosterone (male hormone) to grow. ADT dramatically reduces testosterone levels, which typically slows or stops cancer growth.

Two forms of ADT exist:

1. Medical castration (drugs that lower testosterone):

   • GnRH agonists like Lupron (leuprolide) or Orgovyx (relugolix)
   • CYP17 inhibitors like Zytiga (abiraterone) - often combined with a steroid
   • These are pills or injections given regularly

2. Surgical castration (removal of testicles):

   • Permanent but less commonly chosen today
   • One-time procedure

Expected outcomes: According to NCCN Guidelines, many patients with metastatic hormone-sensitive prostate cancer achieve PSA control (undetectable or very low PSA levels) and stable disease for months to years on ADT alone.

Combination Therapy for Better Control

Research shows that combination therapy often works better than ADT alone for advanced disease:

• ADT + Chemotherapy (Docetaxel): According to NCCN Guidelines, adding chemotherapy early can extend survival and improve PSA response compared to ADT alone
• ADT + Second-line hormone agents: Drugs like abiraterone, enzalutamide, or apalutamide can be added to enhance hormone blockade

Your goal of "keeping it stable" is realistic. Many patients achieve stable disease where PSA remains low and imaging shows no progression for extended periods.

---

2) Alternative Treatments to Avoid Surgery

Good news: Surgery is NOT typically the first-line treatment for metastatic prostate cancer. According to NCCN Guidelines, surgery is generally reserved for localized disease. For your stage 4 disease with lymph node involvement, medical treatments are the standard approach.

Non-Surgical Treatment Options:

A) Radiation Therapy

• External Beam Radiation Therapy (EBRT) or Stereotactic Body Radiation Therapy (SBRT): Can target the primary tumor and specific metastatic sites
• According to NCCN Guidelines, radiation can be used to treat the prostate and involved lymph nodes
• Often combined with hormone therapy for better results

B) Emerging Radiopharmaceutical Treatments According to recent NCCN Guidelines and Cancer Patient Lab webinars on advanced prostate cancer:

• PSMA-targeted therapies (Pluvicto/Lu-177 PSMA): A newer treatment that uses radioactive particles to target cancer cells expressing PSMA (a protein on prostate cancer cells). This is increasingly used for metastatic disease
• Radium-223: For bone metastases specifically
• These are less invasive than surgery and can be very effective

C) Immunotherapy

• Sipuleucel-T (Provenge): An FDA-approved cancer vaccine for metastatic castrate-resistant prostate cancer
• According to NCCN Guidelines, this can be considered for certain patients

D) Targeted Therapy (If Genetic Testing Shows Mutations)

• If your tumor has specific mutations (BRCA1/2, CDK12, mismatch repair deficiency), targeted drugs like PARP inhibitors may be options
• This requires tumor genetic testing

Treatment Sequencing

A typical treatment pathway for your situation might look like:

1. Start ADT (hormone therapy) - often with combination agents
2. Monitor PSA and imaging every 3-6 months
3. If PSA remains undetectable/low → Continue current therapy
4. If PSA rises despite ADT → Add or switch to second-line hormone agents, chemotherapy, or radiopharmaceuticals
5. Radiation to specific sites if needed

---

3) International Treatment Options & Accessibility

What I Found in Medical Literature:

The NCCN Guidelines I have access to are primarily US-based standards of care. However, Cancer Patient Lab webinars document that patients have explored:

• PSMA-targeted therapies (available in Australia, Europe, and select US centers)
• Functional tumor testing (specialized labs that test drug sensitivity on your actual tumor tissue)
• Clinical trials worldwide through platforms like ClinicalTrials.gov or Massive Bio

Important caveat: I don't have comprehensive data on specific international treatment centers or their success rates. This is an area where you'd benefit from specialist guidance.

---

Critical Next Steps (Without Insurance)

Since you mentioned having no insurance and no oncologist, here are practical options:

1. Find an Oncologist

• Community health centers often provide sliding-scale fees based on income
• Academic medical centers (university hospitals) often have financial assistance programs
• Cancer support organizations like the American Cancer Society can help connect you to resources
• Telemedicine oncologists may be more affordable than in-person visits

2. Get Tumor Genetic Testing

• This is crucial for identifying targeted therapy options
• Some labs offer financial assistance programs
• Cost: typically $1,000-3,000, but can guide treatment for years

3. Explore Clinical Trials

• Many trials cover treatment costs
• Search: ClinicalTrials.gov (filter for prostate cancer, metastatic, your location)
• Your oncologist can help identify appropriate trials

4. Questions to Ask Your First Oncologist:

1. "Based on my PSA and imaging, what is my expected PSA response to ADT?"
2. "Should I start combination therapy (ADT + chemotherapy) or ADT alone?"
3. "When should we do tumor genetic testing, and what does it cost?"
4. "What is the monitoring schedule (PSA tests, imaging) to track response?"
5. "If my PSA rises on current therapy, what are the next treatment options?"
6. "Are there clinical trials I'm eligible for?"
7. "What financial assistance programs are available?"

---

Summary: Evidence Coverage

| Topic | Evidence Strength | Key Finding | |-------|-------------------|-------------| | ADT for metastatic disease | ✅ Strong (NCCN Guidelines) | First-line, effective, can achieve stable disease | | Combination therapy options | ✅ Strong (NCCN Guidelines) | ADT + chemotherapy or second-line hormones improve outcomes | | Radiation alternatives | ✅ Strong (NCCN Guidelines) | EBRT, SBRT, PSMA-targeted therapies are standard options | | International treatment centers | ⚠️ Limited in my sources | Requires specialist consultation; ClinicalTrials.gov can help | | Specific international success rates | ⚠️ Not in my knowledge base | Oncologist can research based on your specific case |

---

Your Realistic Outlook

At 76 with no other health problems and good performance status, you're actually in a favorable position for treatment. Many patients with metastatic prostate cancer:

• Achieve undetectable PSA on hormone therapy
• Maintain stable disease for 2-5+ years
• Have good quality of life on current treatments
• Have multiple treatment options if one stops working

Your goal of "keeping it stable" is medically reasonable and achievable with appropriate treatment.

This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.

---

Next action: Prioritize finding an oncologist this week. This is urgent but manageable. Would you like guidance on how to locate affordable oncology care in your area?